B4GALT6 and myeloid sarcoma: Lactosylceramide (LacCer), a ceramide-derived sphingolipid, and the enzyme that catalyzes its synthesis (B4GALT6), are overexpressed in the non-obese diabetic EAE model, which mimics the progressive phenotype of MS; and in MS chronic lesions (109).